Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Wegovy is a GLP-1 agonist containing semaglutide ... increased weekly by 0.6 mg to a maintenance dose of 3.0 mg daily. Common side effects include nausea, diarrhea, vomiting, low blood sugar ...

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

Side effects of compounded drugs ... One FDA page now lists semaglutide as “in shortage,” while another says that all doses are available. The shortage of tirzepatide, the drug used in ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...